Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Morphosys Ag ADR (NQ: MOR )

18.96 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Morphosys Ag ADR

< Previous 1 2 3 4 5 6 7 8 Next >
22 Stocks Moving in Thursday's Pre-Market Session
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares rose 63.2% to $8.03 in pre-market trading after jumping around 8% on Wednesday. Verb Technology Company, Inc. (... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Wednesday morning saw 57 companies set new 52-week lows. Noteworthy Points: Campbell Soup (NYSE:CPB) was the largest firm by market cap to set a new 52-week low.... 
Via Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... 
Via Benzinga
10 Biggest Price Target Changes For Friday
Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.... 
Via Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
Via Benzinga
Exposures Product Safety
Why MorphoSys Stock Sank This Week
Investors weren't happy about the drugmaker's wheeling and dealing. 
Via The Motley Fool
Why Constellation Pharmaceuticals Stock Was Crushing It This Week
The small drugmaker is being acquired by MorphoSys. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021
Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had... 
Via Benzinga
The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,... 
Via Benzinga
66 Biggest Movers From Yesterday
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped... 
Via Benzinga
Mid-Afternoon Market Update: Constellation Pharmaceuticals Surges Following Acquisition News; Protalix BioTherapeutics Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.05% to 34,594.18 while the NASDAQ fell 0.16% to 13,715.08. The S&P also rose, gaining 0.02% to 4,202.76. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Constellation (NASDAQ:CNST) shares rose 67.19% to $33.84 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 19.5... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises 1%; iRhythm Technologies Shares Plunge
`Midway through trading Wednesday, the Dow traded up 0.33% to 34,689.77 while the NASDAQ rose 0.16% to 13,758.43. The S&P also rose, gaining 0.30% to 4,214.55. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Constellation Pharmaceuticals Stock Is Skyrocketing Today
The company is being acquired by MorphoSys. 
Via The Motley Fool
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Advance Auto Parts Profit Tops Estimates
Following the market opening Wednesday, the Dow traded up 0.26% to 34,665.01 while the NASDAQ rose 0.15% to 13,757.62. The S&P also rose, gaining 0.23% to 4,211.85. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks That Hit 52-Week Lows On Wednesday
Before 10 a.m. ET on Wednesday, 8 companies hit new 52-week lows. Highlights: Dun & Bradstreet Hldgs (NYSE:DNB) was the biggest company by market cap to set a new 52-... 
Via Benzinga
Constellation Pharma Rockets On Word Of $1.7 Billion MorphoSys Takeover
MorphoSys announced its $1.7 billion plan to acquire cancer treatment biotech Constellation on Wednesday and CNST stock rocketed to a four-month high. 
Via Investor's Business Daily
Why Constellation Pharmaceuticals Is Soaring Today
Constellation Pharmaceuticals Inc (NASDAQ: CNST) is trading higher Wednesday morning after an announcement that MorphoSys AG (NASDAQ: MOR) will acquire the company. What Happened... 
Via Benzinga
MorphoSys to Acquire Constellation Pharma at $34/Share; Enters $2B Strategic Funding with Royalty Pharma
MorphoSys AG (NASDAQ: MOR) has agreed to acquire Constellation Pharmaceuticals Inc (NASDAQ: CNST) for $34/share in cash, representing a total equity value of... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Constellation (NASDAQ:CNST) shares moved upwards by 66.55% to $33.71 during Wednesday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2021
Upgrades Seaport Global upgraded the previous rating for Public Service Enterprise Group Inc (NYSE:PEG) from Neutral to Buy. Public Service Enterprise earned $1.28 in the... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Conformis (NASDAQ:CFMS) stock moved upwards by 29.53% to $1.09 during Monday's pre-market session. The company's market cap stands at $198.8 million. As... 
Via Benzinga
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
MorphoSys AG (MOR) Q1 2021 Earnings Call Transcript
MOR earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT).... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.